References
- Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005;353:2373–83.
- Somasundaram S, Hayllar H, Rafi S, Wrigglesworth JM, MaCpherson AJS, Bjarnason I. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol 1995;30:289–99.
- Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993;104:1619–26.
- Gotteland M, Cruchet S, Verbeke S. Effect of lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans. Aliment Pharmacol Ther 2001;15:11–7.
- Schoen RT, Vender RJ. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Am J Med 1989;86:449–58.
- Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationship among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126: Suppl:234S–64S.
- Bjarnason I, Hayllar J, Macpherson AJ, Russel AS. Side effects of non-steroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832–47.
- Sigthorsson G, Tibble J, Hayllar J, Menzies I, Macpherson A, Moots R, Intestinal permeability and inflammation in patients on NSAIDs. Gut 1998;43:506–11.
- Uchida M, Kurakazu K. Yogurt containing Lactobacillus gasseri OLL2716 exerts gastroprotective action against acute gastric lesion and antral ulcer in rats. J Pharmacol Sci 2004;96:84–90.
- Tamura A, Kumai H, Nakamichi N, Sugiyama T, Deguchi R, Takagi A, Suppression of Helicobacter pylori-induced interleukin-8 production in vitro and within the gastric mucosa by a live Lactobacillus strain. J Gastroenterol Hepatol 2006;21:1399–406.
- Irons GV, Kirsner JB. Routine chemical tests of the stool for occult blood: an evaluation. Am J Med Sci 1965;249:247–60.